RNA sequencing of amniotic fluid cells for prenatal diagnosis

A clinical research team from the University of Hong Kong (HKUMed) has used amniotic fluid cells obtained during 16-24 weeks of pregnancy as a novel sample type for RNA-sequencing in prenatal diagnosis to help more families with tailored clinical management. This is the first proof-of-concept study to demonstrate the potential clinical utility of amniotic fluid cells RNA-sequencing. The findings have been published in the journal, npj Genomic Medicine.

source https://medicalxpress.com/news/2022-12-rna-sequencing-amniotic-fluid-cells.html